EU Pricing and Reimbursement for Medical Devices and Diagnostics 2006
Informa Healthcare
May 1, 2007 176 Pages - SKU: IFHC1693914
|
|
Overcome reimbursement hurdles and prepare for a successful EU pricing strategy with this new report . EU Pricing and Reimbursement for Medical Devices 2006 will provide an in-depth review of reimbursement issues in 27 European markets.
To improve your understanding of the market, this report includes: - analysis of the medical device market
- structure of the healthcare system
- current and future reforms
- reimbursement structure
Directory of contacts: A unique feature of this report is an invaluable list of key contacts for reimbursement issues, so you know where to go for answers to any specific questions of importance to your company.
Essential questions answered by this report:- How should strategies for gaining reimbursement differ between countries?
- What are the risks associated with selling to the new EU Member States?
|
- CHAPTER 1 INTRODUCTION
- CHAPTER 2 EUROPE
- 2.1 Introduction
- 2.2 Reimbursement
- 2.3 Public tendering
- 2.4 Commonalities to some reimbursement systems
- 2.4.1 Diagnosis related groups
- 2.4.2 Health technology assessment
- 2.5 Other commonalities
- CHAPTER 3 AUSTRIA
- 3.1 Reimbursement system
- 3.1.1 Coding
- 3.1.2 Purchasing
- 3.2 Key Contacts
- CHAPTER 4 BELGIUM
- 4.1 Reimbursement system
- 4.2 Key Contacts
- CHAPTER 5 BULGARIA
- 5.1 Reimbursement system
- 5.2 Key Contacts
- CHAPTER 6 CYPRUS
- 6.1 Reimbursement system
- 6.2 Key Contacts
- CHAPTER 7 THE CZECH REPUBLIC
- 7.1 Reimbursement system
- 7.1.1 Purchasing
- 7.2 Key Contacts
- CHAPTER 8 DENMARK
- 8.1 Reimbursement system
- 8.1.1 Coding
- 8.1.2 Purchasing
- 8.2 Key Contacts
- CHAPTER 9 ESTONIA
- 9.1 Reimbursement system
- 9.2 Key Contacts
- CHAPTER 10 FINLAND
- 10.1 Reimbursement system
- 10.1.1 Coding
- 10.1.2 Purchasing
- 10.2 Key Contacts
- CHAPTER 11 FRANCE
- 11.1 Reimbursement system
- 11.1.1 Coding
- 11.1.2 Reimbursement process
- 11.2 Key Contacts
- CHAPTER 12 GERMANY
- 12.1 Reimbursement system
- 12.1.1 Coding
- 12.1.2 Health technology assessment
- 12.1.3 Reimbursement process
- 12.2 Key Contacts
- CHAPTER 13 GREECE
- 13.1 Reimbursement system
- 13.2 Key Contacts
- CHAPTER 14 HUNGARY
- 14.1 Reimbursement system
- 14.1.1 Coding
- 14.1.2 Procurement
- 14.2 Key Contacts
- CHAPTER 15 IRELAND
- 15.1 Reimbursement system
- 15.1.1 Health technology assessment
- 15.1.2 Coding
- 15.1.3 Purchasing
- 15.2 Key Contacts
- CHAPTER 16 ITALY
- 16.1 Reimbursement system
- 16.1.1 Coding
- 16.1.2 Health technology assessment
- 16.1.3 Other issues
- 16.2 Key Contacts
- CHAPTER 17 LATVIA
- 17.1 Reimbursement system
- 17.2 Key Contacts
- CHAPTER 18 LITHUANIA
- 18.1 Reimbursement system
- 18.2 Key Contacts
- CHAPTER 19 LUXEMBOURG
- 19.1 Reimbursement system
- 19.2 Key Contacts
- CHAPTER 20 MALTA
- 20.1 Reimbursement system
- 20.2 Key Contacts
- CHAPTER 21 THE NETHERLANDS
- 21.1 Reimbursement system
- 21.1.1 Coding
- 21.1.2 Health technology assessment
- 21.2 Key Contacts
- CHAPTER 22 POLAND
- 22.1 Reimbursement system
- 22.2 Key Contacts
- CHAPTER 23 PORTUGAL
- 23.1 Reimbursement system
- 23.1.1 Coding
- 23.1.2 Procurement
- 23.2 Key Contacts
- CHAPTER 24 ROMANIA
- 24.1 Problems and reforms
- 24.2 Reimbursement system
- 24.2.1 Coding
- 24.2.2 Procurement
- 24.3 Key Contacts
- CHAPTER 25 SLOVAKIA
- 25.1 Corruption and reform
- 25.2 Reimbursement system
- 25.2.1 Coding
- 25.2.2 Procurement
- 25.3 Key Contacts
- CHAPTER 26 SLOVENIA
- 26.1 Reforms
- 26.2 Reimbursement system
- 26.2.1 Procurement
- 26.3 Key Contacts
- CHAPTER 27 SPAIN
- 27.1 Reimbursement
- 27.1.1 Health technology assessment
- 27.2 Key Contacts
- CHAPTER 28 SWEDEN
- 28.1 Reimbursement system
- 28.1.1 Coding
- 28.1.2 Procurement
- 28.1.3 Health technology assessment
- 28.2 Key Contacts
- CHAPTER 29 THE UNITED KINGDOM
- 29.1 Reimbursement system
- 29.1.1 Coding
- 29.1.2 Purchasing
- 29.1.3 Health technology assessment
- 29.2 Key Contacts
- LIST OF TABLES
- Table 1.1 European medical device markets ranked by size, 2002
- Table 1.2 EU new Member States’ markets for medical devices ranked by size, 2002
- Table 15.1 Irish Procurement guidelines
- Table 16.1 Regional DRG reimbursement in Italy 2004.
- Table 17.1 Hospital reduction plan in Latvia
- Table 21.1 Differences between US DRG and DBC
- Table 27.1 Products in Annex I or Annex II of Royal Decree 9/1996.
- LIST OF FIGURES
- Figure 7.1 The financing of the Czech Republic’s health system
- Figure 9.1 The financing of Estonia’s health system
- Figure 10.1 The financing of Finland’s health system
- Figure 11.1 Submission of reimbursement application
- Figure 12.1 German reimbursement system as applied to a drug eluting stent
- Figure 13.1 The financing of the Greek health system
- Figure 14.1 The financing of Hungary’s health system
- Figure 16.1 Changes in Italy’s funding structure
- Figure 24.1 Funding for medical devices
Share this report
Other tasks Related Markets General Medical Devices Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|